Ultima-CJC1295 no DAC 2mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE GHRH Peptide

Discover the power of CJC-1295, a cutting-edge synthetic analogue of growth hormone-releasing hormone (GHRH) comprised of 30 amino acids. This remarkable peptide is renowned for its ability to significantly boost the secretion of growth hormone and IGF-1, all while maintaining the natural rhythm of GH release.

Often combined with Ipamorelin for optimal results, CJC-1295 stands out due to its precise action as a GHRH. It effectively elevates growth hormone levels without triggering appetite or increasing cortisol, acetylcholine, prolactin, or aldosterone levels, making it a well-tolerated choice that works synergistically with Ipamorelin.

• Enhanced growth hormone secretion and IGF-1 levels without raising prolactin
• Improved body weight and length through superior protein synthesis
• Greater muscle development
• Increased bone density
• Strengthened immune function
• Enhanced cognitive abilities and memory retention
• Boosted collagen production
• Improved fat loss
• Support for cellular repair and regeneration

CJC-1295 also promotes deep, restorative slow-wave sleep?vital for muscle growth, memory retention, and overall rejuvenation.

GHRH is produced in the hypothalamus, with its pulsatile release stimulating the pituitary gland to secrete GH. However, GHRH has a short half-life of just a few minutes. The first 29 amino acids of GHRH are responsible for its activity and are available as the synthetic peptide Sermorelin. To enhance its half-life to 30 minutes, Sermorelin is modified to create CJC-1295. The addition of a Drug Affinity Complex (DAC) further extends its half-life to eight days, resulting in CJC-1295 + DAC. Alternatively, CJC-1295 can be formulated without the DAC to mimic a natural GH spike each night.

The extended half-life of CJC-1295 means injections are only required once or twice weekly. However, the prolonged presence in the bloodstream provides a continuous stimulus for pituitary GH release, which is not a natural occurrence and may lessen GH pulse amplitude, potentially reducing GH stimulation in tissues.

When utilizing a long-acting CJC molecule, it is recommended to take 'hormone holidays' every three to six months for about three months to allow the pituitary gland to recover. During these breaks, Sermorelin is suggested instead of CJC-1295 + DAC.

These 'hormone holidays' could also minimize the risk of developing GH resistance, which can occur if antibodies form to inactivate GH or if the number of GH receptors decreases in tissues. Although these concerns are theoretical, no long-term studies have been conducted to fully explore them.

Potential side effects of CJC-1295 may include injection site reactions (such as irritation, redness, swelling, pain, or itching), headaches, diarrhea, flushing, temporary low blood pressure, nausea, and abdominal discomfort.